Nn9536-4512
Research payments
$3,156,325
Through program year 2025, $3,156,325 in research payments was reported against Nn9536-4512, across 8,051 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $975,775 | 316 |
| 2024 | Research | $1,602,153 | 2,943 |
| 2023 | Research | $578,397 | 4,792 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Steven Leichter Columbus, GA Named on 891 payments
- Aliu Sanni Loganville, GA Named on 684 payments
- George Freeman Newport News, VA Named on 501 payments
- Thomas Blevins Austin, TX Named on 360 payments
- Clifford Seyler Tullahoma, TN Named on 359 payments
- Daniel Hsia Baton Rouge, LA Named on 353 payments
- Silva Arslanian Pittsburgh, PA Named on 345 payments
- Brent Hella Fargo, ND Named on 337 payments
- Ania Jastreboff New Haven, CT Named on 323 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.